Trials / Completed
CompletedNCT00946504
To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets
A Two-Way Crossover Bioequivalence Study Comparing Single 10 mg Doses of Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioequivalency comparing Geneva's 10 mg Glipizide tablets to Roerig's 10 mg Glucotrol tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.) | |
| DRUG | Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.) |
Timeline
- Start date
- 1992-10-01
- Primary completion
- 1992-10-01
- Completion
- 1992-10-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946504. Inclusion in this directory is not an endorsement.